The elusive coypu: The importance of collateral flow and the search for an alternative to the dog

Cardiovascular Research

Volumn 45, Issue 1, 2000, Pages 215-219

  Hearse, David J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Blood flow; Collateral circulation; Coronary circulation; Coronary disease; Infarction; Ischemia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; GLUCOSE; HYALURONIDASE; RUTOSIDE; SNAKE VENOM; STEROID; VASODILATOR AGENT;

ANIMAL MODEL; COLLATERAL CIRCULATION; DOG; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HISTORY; NONHUMAN; NOTE; PRIORITY JOURNAL; RAT; REPERFUSION; SPECIES DIFFERENCE; SWINE;

EID: 0033991258     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00331-4     Document Type: Note

References (6)

1. Reimer K.A., Jennings R.B., Cobb F.R., et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study. Circ Res. 56:1985;651-665.
2. Hearse D.J. Critical distinctions in the modification of myocardial cell injury. Opie L.H,. Calcium antagonists and cardiovascular disease. 1984;129-145 Raven Press, New York.
3. Hearse D.J. The protection of the ischemic myocardium: surgical success versus clinical failure? Progress in Cardiovascular Diseases. 30:1988;381-482.
4. Hearse D.J., Yellon D.M. Why are we still in doubt about infarct size limitation? the experimentalists view point. Hearse D.J., Yellon D.M. Therapeutic approaches to myocardial infarct size limitation. 1984;17-41 Raven Press, New York.
5. Schaper W. Infarcts and the microcirculation. Hearse D.J., Yellon D.M. Therapeutic approaches to myocardial infarct size limitation. 1984;79-90 Raven Press, New York.
6. Reimer R.A., Jennings R.B. The 'wavefront phenomenon' of myocardial ischemic cell death. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Laboratory Investigation. 40:1979;633-644.